CLINICAL TRIALS PROFILE FOR PERSERIS KIT
✉ Email this page to a colleague
All Clinical Trials for PERSERIS KIT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03978832 ↗ | Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone | Completed | Indivior Inc. | Phase 4 | 2019-06-28 | This study evaluates PERSERIS at a higher dose than what has been administered in previous clinical trials. Subjects with stable schizophrenia on a dose of 5-6 mg oral risperidone will be switched to PERSERIS at the higher dose, which is believed to be similar to the oral dose |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PERSERIS KIT
Condition Name
Clinical Trial Locations for PERSERIS KIT
Trials by Country
Clinical Trial Progress for PERSERIS KIT
Clinical Trial Phase
Clinical Trial Sponsors for PERSERIS KIT
Sponsor Name